Translate
Immutep Ltd
About
Immutep Ltd (AU:IMM) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
Apr 15 2026
Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma
Apr 15 2026
Immutep receives FDA ODD for Efti in Soft Tissue Sarcoma
Mar 19 2026
Immutep Reports Progress from Phase I Study of LAG-3 Agonist for Autoimmune Diseases
Mar 19 2026
Update on Phase I Study of IMP761 for Autoimmune Diseases
Financials
Revenue
A$7.92 M
Market Cap
A$66.32 M
EPS
-0.06